aid: caribou-biosciences

name: Caribou Biosciences

description: 'Caribou Biosciences is a clinical-stage biopharmaceutical company focused on developing transformative genome‑edited allogeneic cell therapies. Leveraging its proprietary CRISPR hybrid RNA‑DNA (chRDNA) technology, Caribou creates off‑the‑shelf CAR‑T cell therapies aimed at treating devastating diseases such as cancers and genetic disorders. The company emphasizes precision genome editing, armored cell therapies, and rapid patient access, positioning itself as a leader in the CRISPR field.'

url: https://raw.githubusercontent.com/api-evangelist/caribou-biosciences/refs/heads/main/apis.yml

x-type: company

x-source: harvest:secondary-market

x-tier: profiled
x-tier-reason: enrichment pass 2026-10-07 (modular-v1; was harvest)

specificationVersion: '0.20'

created: '2026-10-07'

modified: '2026-10-07'

tags:
- Company
- Biotechnology
- Genome Editing
- Cell Therapy
- CRISPR

maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io

common:
- type: Hosts
  url: hosts/caribou-biosciences-hosts.yml
- type: SDKs
  url: packages/caribou-biosciences-packages.yml
- type: Packages
  url: packages/caribou-biosciences-packages.yml
- type: DomainSecurity
  url: security/caribou-biosciences-domain-security.yml
- type: Website
  url: https://www.cariboubio.com
- type: Documentation
  url: https://www.cariboubio.com/technology/
- type: TermsOfService
  url: https://www.cariboubio.com/terms-of-use/
- type: PrivacyPolicy
  url: https://www.cariboubio.com/privacy-policy/

apis: []

x-coverage:
  state: unreadable
  reason: no-machine-readable-spec
  detail: No OpenAPI/AsyncAPI/GraphQL spec found at the API host https://api.cariboubio.com
  evidence:
    - url: https://api.cariboubio.com/openapi.json
      status: 000
  checked: '2026-10-07'
x-enrichment:
  date: '2026-10-07'
  status: enriched
  artifacts_added: 4
  pass: modular-v1
  engine: identity=local,contract=local,surfaces=local,docs=local,regulatory=local